US Maternal Mortality Rate Increased 27% Over 5 Years, NIH Study Finds
A new U.S. government paper documenting an increase in maternal ... Read More
Effect of BMI on Cardiovascular Risk in Rheumatoid Arthritis Varies by Antibody Status and Biologic Use
Body mass index influenced cardiovascular risk in rheumatoid arthritis, with ... Read More
Advancing Equity in Electrophysiology: Don’t Miss ABC’s Featured Session at HRS 2025
ABC is proud to lead a vital conversation at the ... Read More
Watch Now: Empowering Preeclampsia Survivors for Lifelong Heart Health
Did you miss the recent webinar, Strong Hearts, Bright Futures: Empowering ... Read More
Congratulations to the Winner of the ABC Best Abstract Competition at ACC.25!
The ABC is thrilled to announce Sheriff Dodoo, MD, of the ... Read More
Empowering Communities Through Digital Health: The Techquity by FAITH! Digital Health Advocate Training
Transforming Lives with Digital Health Advocacy The Mayo Clinic’s FAITH! ... Read More
Amgen Announces Robust Weight Loss With Maritide In People Living With Obesity Or Overweight At 52 Weeks In A Phase 2 Study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 ... Read More
Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients
– Attruby is the first and only approved product with a ... Read More
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Acoramidis demonstrated the earliest known time to separation in cardiovascular ... Read More